
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
Two Onc Docs
00:00
Peripheral smear and prognostic markers
Sam and Kareen discuss smudge cells, IGHV stability, and favorable versus adverse cytogenetic features.
Play episode from 02:10
Transcript


